Stay updated on Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.

Latest updates to the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedOntario is now listed under the Locations section, replacing the former Ontario Locations label; the page shows Revision: v3.3.3.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedA note that publications are automatically filled from PubMed was added, and the revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the government funding status banner; study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedThe page content appears unchanged between the two screenshots; any differences seem limited to minor formatting or layout adjustments that do not affect the study information or navigation.SummaryDifference0.4%

- Check97 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference3%

- Check104 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.4%

Stay in the know with updates to Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.